Study Stopped
terminated with16 included patients instead of 18
Modulation and Assessment of Mental Flexibility in Dysexecutive Brain Patients
MODEX
1 other identifier
interventional
16
1 country
1
Brief Summary
This project aims to (1) define and characterize brain networks of cognitive flexibility amongst patients with frontal lesions; (2) quantify the effects of ecological cognitive trainings and brain stimulation on behavioral performance and brain networks; (3) identify predictive markers of effective rehabilitation (patients)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2020
CompletedStudy Start
First participant enrolled
February 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2022
CompletedJuly 19, 2023
July 1, 2023
2.9 years
January 31, 2020
July 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evolution of performance at GAS (Goal Attainment scaling) in long term
The main judgement criterion will be the evolution of performance at GAS (Goal Attainment Scaling) in the month following the cognitive training phase, according to the individual objectives defined at the beginning of the procedure with each patient, compared to the baseline phase
The month following the cognitive training phase (TF+1)
Secondary Outcomes (3)
Evolution of performance at GAS (Goal Attainment scaling) in short term
Just after the cognitive training phase (TF)
Reaction time when performing TEA battery: Test of Everyday Attention
Before the cognitive training phase (T0), just after the cognitive training phase (TF) and the month following the cognitive training phase (TF+1)
Score at TEA battery: Test of Everyday Attention
Before the cognitive training phase (T0), just after the cognitive training phase (TF) and the month following the cognitive training phase (TF+1)
Study Arms (3)
Arm 1 (early phase B)
EXPERIMENTAL3 phases of cognitive training: Phase A1: rehabilitation program in standard ergotherapy during 3 weeks Phase B: cognitive training using Covirtua software and Transcranial random noise stimulation during 4 weeks Phase A2: return to the standard rehabilitation program in standard ergotherapy during 5 weeks
Arm 2 (mid phase B)
EXPERIMENTAL3 phases of cognitive training: Phase A1: rehabilitation program in standard ergotherapy during 4 weeks Phase B: cognitive training using Covirtua software and Transcranial random noise stimulation during 4 weeks Phase A2: return to the standard rehabilitation program in standard ergotherapy during 4 weeks
Arm 3 (late phase B)
EXPERIMENTAL3 phases of cognitive training: Phase A1: rehabilitation program in standard ergotherapy during 5 weeks Phase B: cognitive training using Covirtua software and Transcranial random noise stimulation during 4 weeks Phase A2: return to the standard rehabilitation program in standard ergotherapy during 3 weeks
Interventions
Rehabilitation program in standard ergotherapy and cognitive training with Covirtua Software and Transcranial random noise stimulation
Eligibility Criteria
You may qualify if:
- Affiliated to social security
- Signed informed consent
- Mother tongue: French
- Right handed (Edimburg Scale)
- Frontal traumatic brain injury or stroke responsible for a dysexecutive syndrome assessed by the GREFEX battery.
You may not qualify if:
- Claustrophobia
- Addiction
- Major Hearing or Visual loss
- Hearing prosthesis
- Metal intraocular implant
- Cardiac prosthesis
- High Blood pressure
- Severe cardiac insufficiency
- Uncompensated thyroid disorders
- Major neuropsychological disorder
- Family or personal history of epilepsy
- Pregnancy
- Female subject of childbearing age not receiving effective contraception.
- Participation in another experimental protocol involving brain stimulation within the last 4 weeks
- Person under the protection of justice, tutorship or curatorship
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Toulouselead
- ISAE-SUPAEROcollaborator
Study Sites (1)
Universty hospital of Toulouse (Rangueil)
Toulouse, 31059, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xavier De Boissezon, MD
University Hospital, Toulouse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2020
First Posted
February 5, 2020
Study Start
February 4, 2020
Primary Completion
December 13, 2022
Study Completion
December 13, 2022
Last Updated
July 19, 2023
Record last verified: 2023-07